Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
First, this analysis was based on aggregated arm-level data rather than individual participant data, which limited the ability to adjust for patient-level heterogeneity, including comorbidities and concomitant therapies
South Med J (2006) 99:25774
Patients with higher baseline hemoglobin A1c levels (above 9%) typically experience more rapid and pronounced glucose reductions compared to those with A1c levels closer to target
In accordance with the relevant law or company policy, only the star ratings are disclosed
Can You Combine Both
US$ 20.50
US$ 29.68
US$ 20.46
US$ 26.81
